摘要
胆碱是一种季铵盐,并作为不同膜磷脂的重要组成部分,有助于细胞膜结构的完整性。含胆碱磷脂(CCPLs)包括磷脂酰胆碱(PC),鞘磷脂(SM),甘磷酸胆碱(GPC)。在大多数真核细胞中,聚碳酸酯 是主要的磷脂。它参与SM合成,胆碱/胆碱代谢物重新生成,和脂肪酸/凝胶的形成。本文综述了化学、生物学和治疗的特点关于分析得出的CCPLs,a)外源CCPLs效应,b)GPC治疗脑胆碱能神经传递的影响,c)神经保护作用GPC单独或与乙酰胆碱酯酶抑制剂在脑血管损伤动物模型的关联,d)胆碱类似物的合成,包括含有短链烷基取代甲基。胞苷二磷酸胆碱和GPC,保护细胞膜,可以在治疗脑血管意外后遗症有帮助。此外,细胞膜破裂还作为一个无论是在急性(中风)和慢性(阿尔茨海默和血管性痴呆)的脑功能障碍的特征。公布的数据都集中到一个更大的程度上的生物合成,细胞生命活动相关的作用,和与胆碱能神经传递的CCPLs至关重要的参与。由发表的临床研究表明了在治疗脑血管和神经退行性疾病方面的可能性。在这些潜在的实际应用药物治疗中,对神经系统疾病的胆碱能损伤可能的活性胆碱衍生物的合成研究领域需要进一步的研究讨论。
关键词: 含胆碱磷脂、脑血管病、甘磷酸胆碱,胞二磷胆碱,胆碱衍生物的合成。
Current Medicinal Chemistry
Title:Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications
Volume: 22 Issue: 38
Author(s): S.K. Tayebati, G. Marucci, C. Santinelli, M. Buccioni and F. Amenta
Affiliation:
关键词: 含胆碱磷脂、脑血管病、甘磷酸胆碱,胞二磷胆碱,胆碱衍生物的合成。
摘要: Choline is a quaternary ammonium salt, and being an essential component of different membrane phospholipids (PLs) contributes to the structural integrity of cell membranes. Choline-containing phospholipids (CCPLs) include phosphatidylcholine (PC), sphingomyelin (SM), and choline alphoscerate (GPC). PC is the major phospholipid in most eukaryotic cells. It is involved in SM synthesis, choline/choline metabolite re-generation, and fatty acid/GPC formation. This paper has reviewed chemical, biological and therapeutic features of CCPLs by analyzing: a) effects of exogenous CCPLs, b) influence of GPC treatment on brain cholinergic neurotransmission, and c) neuroprotective effects of GPC alone or in association with acetylcholinesterase inhibitors in animal models of brain vascular injury, d) synthesis of the choline analogs, containing a short alkyl chain instead of a methyl group. Cytidine-diphosphocholine and GPC, protect cell membranes and could be helpful in the sequelae of cerebrovascular accident treatment. Moreover, cellular membrane breakdown is suggested as a feature of neurodegeneration both in acute (stroke) and in chronic (Alzheimer and vascular dementia) brain disorders. Published data were focused to a larger extent on the biosynthesis, relevant role in cell life, and crucial involvement of CCPLs in cholinergic neurotransmission. The possibility of their use in the treatment of cerebrovascular and neurodegenerative disorders is suggested by published clinical studies. In line with these potential practical applications in pharmacotherapy, the need of further research in the field of the synthesis of new choline derivatives with possible activity in nervous system diseases characterized by cholinergic impairment is discussed.
Export Options
About this article
Cite this article as:
S.K. Tayebati, G. Marucci, C. Santinelli, M. Buccioni and F. Amenta , Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications, Current Medicinal Chemistry 2015; 22 (38) . https://dx.doi.org/10.2174/0929867322666151029104152
DOI https://dx.doi.org/10.2174/0929867322666151029104152 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Catatonia: A Narrative Review
Central Nervous System Agents in Medicinal Chemistry Winning a Won Game: Caffeine Panacea for Obesity Syndemic
Current Neuropharmacology Issues in Rehabilitation of Cognitive Deficits in Schizophrenia: A Critical Review
Current Psychiatry Reviews The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye Development
Current Molecular Medicine Cognitive, Psychological and Psychiatric Effects of Ionizing Radiation Exposure
Current Medicinal Chemistry Can FreeSurfer Compete with Manual Volumetric Measurements in Alzheimer’s Disease?
Current Alzheimer Research Molecular Basis for the Neuroprotective Properties of FKBP-Binding Immunophilin Ligands
Current Medicinal Chemistry - Central Nervous System Agents Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis
Current Alzheimer Research Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier
Current Drug Metabolism Clopidogrel in Secondary Ischemic Stroke Prevention
Recent Patents on Cardiovascular Drug Discovery Molecular and Biochemical Features in Alzheimers Disease
Current Pharmaceutical Design Inducers of Heme Oxygenase-1
Current Pharmaceutical Design NMDA Receptors are not Alone: Dynamic Regulation of NMDA Receptor Structure and Function by Neuregulins and Transient Cholesterol-Rich Membrane Domains Leads to Disease-Specific Nuances of Glutamate- Signalling
Current Topics in Medicinal Chemistry Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression
Current Pharmaceutical Design Editorial: Targeting Cerebral Vascular Injury for Intervention
Current Drug Delivery Neuron-to-microglia Crosstalk in Psychiatric Disorders
Current Neuropharmacology Calcium Channel Blockade and Peroxisome Proliferator Activated Receptor γ Agonism Diminish Cognitive Loss and Preserve Endothelial Function During Diabetes Mellitus
Current Neurovascular Research Effects of 900MHz Mobile Phone Radiation on Human Thyroid Hormone Levels
Recent Patents on Biomarkers Corticosteroids for the Inflammatory Response to Cardiopulmonary Bypass: An Update
Current Pharmaceutical Design γ-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes
Current Topics in Medicinal Chemistry